Ajinomoto Co Inc, which holds a majority 50.38% stake in Ajinomoto Malaysia, has announced its intention to privatise the monosodium glutamate producer through a structured capital repayment scheme worth RM603.4 million. The move targets minority shareholders who collectively own 49.62% of the company, providing them with a clearly defined exit opportunity at an attractive valuation that represents a significant premium to recent market prices.
The privatisation represents a strategic consolidation by the Japanese multinational, which has historically maintained a controlling position in the Malaysian operations while leaving the company listed on Bursa Securities. By taking the company private, Ajinomoto Co Inc seeks to eliminate the administrative burden and public reporting obligations associated with maintaining a stock market listing, particularly given that the company has not accessed capital markets for more than a decade. This shift reflects a broader trend among multinational corporations with mature, stable subsidiaries to move away from public equity structures when capital raising is no longer a priority.
Minority shareholders will receive RM20 per share in cash, calculated through a capital repayment mechanism. This valuation anchors significantly above recent trading metrics: it represents a 31.58% premium to the closing price of RM15.20 recorded on the last trading day before the suspension, and sits between 30.68% and 49.93% above the five-day and one-year volume weighted average price benchmarks. For investors who have held positions through extended periods of illiquidity, the offer provides a meaningful opportunity to realise holdings at prices substantially better than those available in normal market conditions.
A persistent challenge underlying this privatisation proposal is the chronic illiquidity that has characterised Ajinomoto Malaysia shares. Over the past five years, average daily trading volume has languished at merely 38,715 shares—a turnover rate so negligible that executing substantial positions without material price movement would prove nearly impossible. This structural liquidity deficiency has rendered the public listing functionally irrelevant for the purposes of price discovery or capital allocation, transforming the company's status on Bursa Securities into little more than a regulatory formality. The proposed buyout therefore serves partly as a recognition of this reality: the shares have not truly traded as a liquid public security despite their technical listing status.
The mechanics of the delisting involve a creative capital restructuring that permits Ajinomoto Malaysia to manage its balance sheet efficiently while executing the privatisation. The company will issue a substantial bonus of 571.11 million new shares, funded through a RM571.1 million capitalisation of retained earnings. This bonus capitalisation bridges the gap between the RM603.4 million capital repayment obligation to minority shareholders and the company's existing issued capital of RM65.1 million across 60.8 million shares. Once this bonus issue is completed, all shares held by the entitled minority shareholders will be cancelled, leaving Ajinomoto Co Inc with 100% ownership.
From an operational perspective, the parent company's stated rationale addresses the inefficiencies inherent in maintaining a subsidiary's public company status when consolidated ownership is desired. Currently, Ajinomoto Malaysia must allocate management resources to meet Bursa Securities disclosure requirements, securities regulatory filings, and the general compliance infrastructure demanded of listed entities. By eliminating these regulatory obligations, the subsidiary can streamline its corporate structure and redeploy the capital and administrative effort currently spent on listing maintenance toward commercial initiatives and enhancing operational efficiency. The proposal letter emphasises that the delisting will grant greater strategic flexibility in business execution without the drag of continuous reporting cycles.
The Malaysian context adds particular relevance to this transaction. Ajinomoto Malaysia operates as a significant local producer of monosodium glutamate, a flavouring ingredient with deep penetration across Southeast Asian food manufacturing, food service, and household segments. The company's position within Malaysia's broader food chemicals and additives sector has remained stable over decades, though the mature nature of the market limits growth expectations. Consolidating ownership under the Japanese parent potentially positions the subsidiary for tighter integration with Ajinomoto's regional supply chains and product distribution networks, though such strategic shifts remain subject to management's post-delisting discretion.
For minority shareholders, timing considerations deserve careful attention. The RM20 per share offer will not remain open indefinitely—delisting timelines typically compress shareholder decision windows. Those who accept the offer will realise their investment within a defined period and with complete certainty of valuation, eliminating ongoing exposure to Ajinomoto Malaysia's operational performance or broader equity market volatility. Conversely, shareholders who might harbour expectations of higher valuations or believe the company's prospects warrant a premium will face a difficult choice between accepting the offered price or remaining locked into an illiquid security with no obvious path to better realisation.
The suspension of trading commenced on June 22, 2026, with resumption scheduled for June 23, 2026, creating a brief window during which the trading halt allows the market to absorb news of the proposal. This trading halt prevents information asymmetries from distorting the share price during what will likely be a chaotic and emotional period for minority shareholders responding to the announcement. Once trading resumes, market activity may spike as shareholders position themselves either to accept the offer or explore alternatives, though the structured nature of the capital repayment scheme substantially constrains negotiating room.
Broader implications for Malaysian equity markets and foreign-controlled subsidiaries merit consideration. The privatisation reflects pragmatic thinking among multinational parents: when public listing status no longer serves capital-raising functions and instead primarily generates compliance costs, consolidating ownership becomes economically sensible. This pattern may accelerate across Southeast Asia as mature multinational subsidiaries reassess the cost-benefit calculation of public equity status. For regulators and exchanges, such privatisation trends underscore the importance of ensuring that minority shareholder protections—including fairness of valuation and adequacy of disclosure—remain robust even as listing prevalence potentially declines among stable, non-growth-stage subsidiaries.
